Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for fesoterodine fumarate submitted by Alembic Pharmaceuticals Inc. Fesoterodine fumarate is used to treat overactiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

SUPPL AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)